The LPL Expert Breast Cancer Panel Test is a specialized genetic test available at DNA Labs UAE, designed to identify specific mutations in genes associated with an increased risk of developing breast cancer. This test plays a crucial role in the early detection and prevention of breast cancer by providing individuals with vital information about their genetic predisposition to the disease. By analyzing DNA samples, the panel can pinpoint mutations in the LPL gene, among others, that are linked to breast cancer, enabling healthcare professionals to tailor personalized prevention and treatment plans for their patients. The cost of the LPL Expert Breast Cancer Panel Test at DNA Labs UAE is 1520 AED, making it an accessible option for those seeking to understand their genetic risk factors for breast cancer. This test is particularly recommended for individuals with a family history of breast cancer or other related cancers, as it can provide peace of mind or guide in taking proactive measures towards health management.
The Multiple Sclerosis Panel 1 Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect biomarkers associated with Multiple Sclerosis (MS), a chronic autoimmune disease that affects the central nervous system. Priced at 1520 AED, this test aims to provide critical insights into the genetic predisposition and immune system irregularities linked to MS, facilitating early detection and personalized treatment strategies. By analyzing specific genetic markers and immune responses, the test can help healthcare professionals tailor interventions and monitor disease progression, offering hope for better management of this complex condition.
Myotonic Dystrophy Type 2, also known as DM2 or proximal myotonic myopathy (PROMM), is a genetic disorder characterized by muscle weakness and myotonia, which is an inability to relax muscles at will. This condition varies in its presentation and severity, affecting not only the muscles but potentially also the heart, endocrine system, and central nervous system. Unlike Myotonic Dystrophy Type 1, DM2 tends to have a later onset and often presents milder symptoms.
To diagnose Myotonic Dystrophy Type 2, a specific genetic test is conducted to identify the presence of a mutation in the CNBP (ZNF9) gene, which is the hallmark of DM2. This mutation involves an expansion of a CCTG repeat in the gene. The genetic test for DM2 is crucial for accurate diagnosis, guiding treatment options, and providing information on the genetic risk for family members.
In the United Arab Emirates, DNA Labs UAE offers a comprehensive testing service for Myotonic Dystrophy Type 2. The test is priced at 1520 AED, reflecting the specialized nature of the genetic analysis. Conducted in a state-of-the-art laboratory by skilled geneticists, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for the specific genetic mutation associated with DM2.
Upon completion, the test provides individuals and their healthcare providers with crucial information regarding the diagnosis, allowing for a better understanding of the condition and the development of a tailored management plan. This can include strategies to manage symptoms, monitor potential complications, and offer genetic counseling for affected individuals and their families.
The "Sanger Sequencing Single Variant Test," offered at DNA Labs UAE for a cost of 1520 AED, is a precise genetic test designed to analyze and detect specific mutations or variants within an individual's DNA. This technique, named after its developer, Frederick Sanger, is a cornerstone method in molecular biology for determining the exact sequence of nucleotides in a segment of DNA. The test is particularly useful for confirming the presence of known genetic mutations associated with various inherited diseases and conditions. By focusing on a single variant, it offers a highly targeted approach, making it ideal for cases where a specific genetic alteration is suspected based on family history or other diagnostic indicators. DNA Labs UAE employs state-of-the-art technology and expertise to ensure accurate and reliable results, making it a trusted choice for patients and healthcare providers seeking detailed genetic insights.
The Vitamin B1 Thiamine Test is a crucial diagnostic tool designed to measure the levels of thiamine in the blood. Thiamine, also known as Vitamin B1, plays a vital role in energy metabolism and the proper functioning of the nervous system, muscles, and heart. Deficiency in thiamine can lead to a range of health issues, including beriberi, Wernicke-Korsakoff syndrome, and general weakness or fatigue.
This test is particularly recommended for individuals experiencing symptoms of thiamine deficiency, those with conditions that impair thiamine absorption (like chronic alcoholism), or people with a diet lacking in this essential nutrient. It's also valuable for monitoring the effectiveness of thiamine supplementation in diagnosed cases.
Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic solutions, the Vitamin B1 Thiamine Test ensures accuracy and reliability in results. The test cost is set at 1520 AED, reflecting the comprehensive approach and the state-of-the-art technology employed in the analysis. Getting tested is straightforward, with professional staff guiding patients through the process, ensuring a seamless experience from start to finish.
The PML/RARA Quantitative Single Form Test is a specialized diagnostic assay utilized for the detection and quantification of the PML/RARA fusion gene, which is primarily associated with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). This test plays a crucial role in the diagnosis, prognosis, and monitoring of treatment response in patients with APL. Utilizing advanced molecular techniques, the test accurately measures the levels of the PML/RARA transcript in blood or bone marrow samples, providing essential information for personalized patient management.
Conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive range of genetic and molecular diagnostic services, the PML/RARA Quantitative Single Form Test is performed under stringent quality control measures to ensure accuracy and reliability. The cost of the test is set at 1520 AED, reflecting the sophisticated nature of the technology and expertise involved in conducting the assay. For patients and healthcare providers, this test represents a critical tool in the effective management of acute promyelocytic leukemia, offering insights that guide treatment decisions and contribute to improved outcomes.
The IgA Subclasses Test is a specialized diagnostic procedure aimed at measuring the levels of Immunoglobulin A (IgA) subclasses in the blood. IgA is a critical antibody that plays a vital role in the immune response, particularly in the mucosal areas of the body such as the gut, respiratory tract, and saliva. There are two subclasses of IgA, namely IgA1 and IgA2, each serving unique functions in immune defense. This test is crucial for identifying deficiencies or abnormalities in these subclasses, which can be indicative of various immune disorders, infections, and allergic reactions.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the IgA Subclasses Test is priced at 1260 AED. The test involves a simple blood draw, after which the sample is analyzed using sophisticated laboratory techniques to accurately measure the levels of IgA1 and IgA2. Results from this test can provide valuable insights into a patient's immune system status, aiding healthcare professionals in diagnosing conditions such as Selective IgA Deficiency, Common Variable Immune Deficiency (CVID), and other immune-related disorders. The detailed and reliable analysis offered by DNA Labs UAE makes it a preferred choice for patients and healthcare providers seeking comprehensive immune system assessments.
The FISH (Fluorescence In Situ Hybridization) Microdeletion Detection for Williams Syndrome test is a specialized genetic diagnostic procedure available at DNA Labs UAE. Priced at 1510 AED, this test is designed to identify the specific microdeletion in the 7q11.23 region of chromosome 7, which is characteristic of Williams Syndrome. Williams Syndrome is a genetic disorder that affects many parts of the body and is known for causing developmental delays, cardiovascular issues, and unique facial features among affected individuals. The FISH test uses fluorescent probes to visualize the presence or absence of genetic material in this specific chromosome region, providing a reliable diagnosis of Williams Syndrome. This test is crucial for early detection and management of the syndrome, offering families and healthcare providers vital information for care planning.
The Fish - Prader Willi Syndrome SNRPN Test is a specialized genetic examination aimed at diagnosing Prader-Willi Syndrome (PWS), a complex genetic disorder characterized by a variety of physical, mental, and behavioral features. This test specifically targets the SNRPN gene, which plays a crucial role in the development of PWS. It employs fluorescence in situ hybridization (FISH) technology to detect abnormalities associated with the SNRPN gene, such as deletions or uniparental disomy, which are common genetic mechanisms underlying Prader-Willi Syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test provides a reliable diagnosis for families seeking answers to developmental delays, feeding difficulties in infancy, followed by excessive eating and weight gain in older children and adults, among other symptoms associated with PWS. The cost of the test is 1500 AED, making it a valuable investment for those in need of a definitive diagnosis, which can lead to early intervention and management strategies tailored to the specific needs of individuals with Prader-Willi Syndrome.
The CYP3A4*22 Genotyping Test is a specialized diagnostic tool designed to analyze the CYP3A4 gene, specifically the *22 allele, to predict an individual's response to various medications. This test is crucial because the CYP3A4 enzyme is responsible for metabolizing approximately half of all drugs in the market, including statins, antipsychotics, and several cancer medications. Variations in the CYP3A4 gene, such as the *22 allele, can significantly affect drug metabolism, leading to either suboptimal drug efficacy or increased risk of adverse drug reactions.
Performed at DNA Labs UAE, the test aims to provide personalized medication guidance based on genetic makeup. By identifying whether an individual has the CYP3A4*22 variant, healthcare providers can adjust drug dosages or choose alternative medications, enhancing treatment effectiveness and safety.
The cost of the CYP3A4*22 Genotyping Test at DNA Labs UAE is 1500 AED. This investment in personalized medicine not only contributes to more tailored healthcare strategies but also minimizes the trial-and-error approach often associated with prescribing medications, offering a more efficient and patient-centered approach to medical treatment.
